(Q43001319)

12 November 2017

Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C. (English)

1 reference

12 November 2017

10

I Nakano

1 reference

12 November 2017

H Toyoda

1

1 reference

12 November 2017

T Kumada

2

1 reference

12 November 2017

A Tokuda

3

1 reference

12 November 2017

Y Horiguchi

4

1 reference

12 November 2017

H Nakano

5

1 reference

12 November 2017

T Honda

6

1 reference

12 November 2017

S Nakano

7

1 reference

12 November 2017

K Hayashi

8

1 reference

12 November 2017

Y Katano

9

1 reference

12 November 2017

T Hayakawa

11

1 reference

12 November 2017

D Nishimura

12

1 reference

12 November 2017

K Kato

13

1 reference

12 November 2017

K Imada

14

1 reference

12 November 2017

M Imoto

15

1 reference

12 November 2017

Y Fukuda

16

1 reference

12 November 2017

Yon-Ken HCV-HCC Follow-up Study Group

17

1 reference

12 November 2017

1 November 2000

1 reference

Journal of Viral Hepatitis

12 November 2017

1 reference

12 November 2017

7

1 reference

12 November 2017

6

1 reference

12 November 2017

414-419

1 reference

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

12 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Therapy of hepatitis C: interferon alfa-2a trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Predictive value of serum sex hormone binding globulin for the occurrence of hepatocellular carcinoma in male patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Eradication of hepatitis C virus RNA after alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

21 January 2018

Therapy of Hepatitis C

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Significance of specific antibody assay for genotyping of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Presence of viral replicative intermediates in the liver and serum of patients infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Eradication of hepatitis C virus after interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Detection of hepatocellular carcinoma after interferon therapy for chronic hepatitis C: clinical study of 26 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00241.X

10.1046/J.1365-2893.2000.00241.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference